Α-Fetoprotein Mrna Detection in Peripheral Blood and Bone Marrow in Patients with Hepatocellular Carcinoma and Its Sigificance

黄东胜,傅佩芬,郑树森,梁廷波,谢海洋

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2002.03.009

2002-01-01

Abstract:Objective To investigate the expression of α-fetoprotein (AFP) mRNA in peripheral blood and bone marrow of hepatocellular carcinoma (HCC) and probe into the possibility of AFP mRNA as a marker of micrometastasis in HCC. Methods A sensitive nested-RT-PCR system was set up to detect the AFP mRNA in peripheral blood of 71 HCC patients, 36 cirrhotic patients, 9 liver hemangioma patients and 11 metastatic liver carcinoma patients. Another 30 non-hepatobiliary system disease patients were employed to serve as the control. AFP mRNA in the bone marrow of 19 HCC patients was compared with that of 15 patients with hematologic diseases. Results Thirty-eight of the 71 HCC patients (53.5%) were positive for AFP mRNA in their peripheral blood while other patients were all negative. The presence of detectable AFP mRNA in peripheral blood was correlated to clinical characteristics such as tumor size, portal vein tumor thrombus (PVTT), intrahepatic metastasis and extrahepatic metastasis except for serum AFP level. Nine of the 19 HCC patients (47.4%) were positive for AFP mRNA in their bone marrow and no positive bands were found in 15 patients with hematologic diseases. The positive results in bone marrow were correlated with tumor size, PVTT, extrahepatic metastasis but not with serum AFP level and intrahepatic metastasis. The presence of AFP mRNA in peripheral blood was consistent with that in bone marrow. Conclusions Blood AFP mRNA can be a early detection marker for micrometastasis. The AFP mRNA test findings in peripheral blood and bone marrow are significantly correlated with recurrence and metastasis. The expression of AFP mRNA in peripheral blood was consistent with that in bone marrow. Therefore, the combined detection may enhance the reliability of the results.